The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease
Open accessAbstract
The long-term goal of nuclear transfer or alternative reprogramming approaches is to create patient-specific donor cells for transplantation therapy, avoiding immunorejection, a major complication in current transplantation medicine. It was recently shown that the four transcription factors Oct4, Sox2, Klf4, and c-Myc induce pluripotency in mouse fibroblasts. However, the therapeutic potential of induced pluripotent stem (iPS) cells for neural cell replacement strategies remained unexplored. Here, we show that iPS cells can be efficiently differentiated into neural precursor cells, giving rise to neuronal and glial cell types in culture. Upon transplantation into the fetal mouse brain, the cells migrate into various brain regions and differentiate into glia and neurons, including glutamatergic, GABAergic, and catecholaminergic subtypes. Electrophysiological recordings and morphological analysis demonstrated that the grafted neurons had mature neuronal activity and were functionally integrated in the host brain. Furthermore, iPS cells were induced to differentiate into dopamine neurons of midbrain character and were able to improve behavior in a rat model of Parkinson's disease upon transplantation into the adult brain. We minimized the risk of tumor formation from the grafted cells by separating contaminating pluripotent cells and committed neural cells using fluorescence-activated cell sorting. Our results demonstrate the therapeutic potential of directly reprogrammed fibroblasts for neuronal cell replacement in the animal model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationTransplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,999
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationKim, J.-H., Auerbach, J. M., Rodríguez-Gómez, J. A., Velasco, I., Gavin, D., Lumelsky, N., Lee, S.-H., Nguyen, J., Sánchez-Pernaute, R., Bankiewicz, K., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,607
Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells
Lee, S.-H., Lumelsky, N., Studer, L., Auerbach, J. M., & McKay, R. D. (2000) · Nature Biotechnology · doi:10.1038/76536 · Cited by 1,257
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Self-citationBjörklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Chen, I. Y. C., McNaught, K. S. P., Brownell, A.-L., Jenkins, B. G., Wahlestedt, C., Kim, K.-S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022438099 · Cited by 1,170
Self-citationTRANSPLANTATION OF EMBRYONIC DOPAMINE NEURONS FOR SEVERE PARKINSON'S DISEASE
Reed, R., Reene, P. A. E. G., Reeze, R. O. E. B., Ei, W., Ouchel, W. I. D. U. M., Ao, R. I. K., Infield, W., Ulver, S. H. C., Rojanowski, J. O. Q. T., Idelberg, D. A. E., et al. (2001) · Cited by 1,001
Stem cells for the treatment of neurological disorders
Lindvall, O., & Kokaia, Z. (2006) · Nature · doi:10.1038/nature04960 · Cited by 829
Roy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006) · Nature Medicine · doi:10.1038/nm1495 · Cited by 821
Okabe, S., Forsberg-Nilsson, K., Spiro, A. C., Segal, M., & McKay, R. D. G. (1996) · Mechanisms of Development · doi:10.1016/0925-4773(96)00572-2 · Cited by 770
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Self-citationDopamine release from nigral transplants visualized in vivo in a Parkinson's patient
Piccini, P., Brooks, D. J., Björklund, A., Gunn, R. N., Grasby, P. M., Rimoldi, O., Brundin, P., Hagell, P., Rehncrona, S., Widner, H., et al. (1999) · Nature Neuroscience · doi:10.1038/16060 · Cited by 700
Barberi, T., Klivenyi, P., Calingasan, N. Y., Lee, H., Kawamata, H., Loonam, K., Perrier, A. L., Bruses, J., Rubio, M. E., Topf, N., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt870 · Cited by 623
Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene Therapy
Rideout, W. M., Hochedlinger, K., Kyba, M., Daley, G. Q., & Jaenisch, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00681-5 · Cited by 599
Self-citationDifferentiation of Embryonic Stem Cell Lines Generated from Adult Somatic Cells by Nuclear Transfer
Wakayama, T., Tabar, V., Rodriguez, I., Perry, A. C. F., Studer, L., & Mombaerts, P. (2001) · Science · doi:10.1126/science.1059399 · Cited by 558
Mendez, I., Sanchez-Pernaute, R., Cooper, O., Viñuela, A., Ferrari, D., Björklund, L., Dagher, A., & Isacson, O. (2005) · Brain · doi:10.1093/brain/awh510 · Cited by 438
Self-citationPakkenberg, B., Moller, A., Gundersen, H. J., Mouritzen Dam, A., & Pakkenberg, H. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 407
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396
Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke
Erdö, F., Bührle, C., Blunk, J., Hoehn, M., Xia, Y., Fleischmann, B., Föcking, M., Küstermann, E., Kolossov, E., Hescheler, J., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071886.63724.fb · Cited by 355
Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell Therapy
Hochedlinger, K., & Jaenisch, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035397 · Cited by 322
Self-citationMarkers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations
Pruszak, J., Sonntag, K.-C., Aung, M. H., Sanchez-Pernaute, R., & Isacson, O. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0744 · Cited by 320
Self-citationIn vitro -generated neural precursors participate in mammalian brain development
Brüstle, O., Spiro, A. C., Karram, K., Choudhary, K., Okabe, S., & McKay, R. D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14809 · Cited by 311
Yang, D., Zhang, Z.-J., Oldenburg, M., Ayala, M., & Zhang, S.-C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0494 · Cited by 284
Cell transplantation in Parkinson's disease: how can we make it work?
Winkler, C., Kirik, D., & Björklund, A. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.006 · Cited by 255
Lee, C. S. (2000) · Brain · doi:10.1093/brain/123.7.1365 · Cited by 212
Therapeutic potential of embryonic stem cells
LEROU, P., & DALEY, G. (2005) · Blood Reviews · doi:10.1016/j.blre.2005.01.005 · Cited by 208
Host-guided migration allows targeted introduction of neurons into the embryonic brain
Brüstle, O., Maskos, U., & McKay, R. D. G. (1995) · Neuron · doi:10.1016/0896-6273(95)90007-1 · Cited by 206
Development of functional human embryonic stem cell-derived neurons in mouse brain
Muotri, A. R., Nakashima, K., Toni, N., Sandler, V. M., & Gage, F. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509315102 · Cited by 182
Functional Integration of Embryonic Stem Cell-Derived Neurons In Vivo
Wernig, M., Benninger, F., Schmandt, T., Rade, M., Tucker, K. L., Büssow, H., Beck, H., & Brüstle, O. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0428-04.200 · Cited by 180
Self-citationParish, C. L., Castelo-Branco, G., Rawal, N., Tonnesen, J., Sorensen, A. T., Salto, C., Kokaia, M., Lindvall, O., & Arenas, E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32273 · Cited by 179
Problems with long-term levodopa therapy for Parkinson's disease.
MARSDEN, C. D. (1994) · PubMed · Cited by 168
Human Cloning — The Science and Ethics of Nuclear Transplantation
Jaenisch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048304 · Cited by 103
Self-citationThe production and use of cells as therapeutic agents in neurodegenerative diseases
Isacson, O. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00437-x · Cited by 100
Self-citationHedlund, E., Pruszak, J., Ferree, A. W., Viñuela, Á., Hong, S., Ole Isacson, A., & Kim, K. S. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0540 · Cited by 69
Self-citationPharmacodynamic Interactions Between Phenytoin and Valproate
Chez, M. G., Bourgeois, B. F. D., Pippenger, C. E., et al. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199402000-00003 · Cited by 61
Weissman, I. L. (2006) · Nature · doi:10.1038/439145a · Cited by 43
Björklund, L. M., & Ole Isacson, A. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)38090-7 · Cited by 40
Cited by
Kriks, S., Shim, J.-W., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,907
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
“Although the therapeutic potential of iPSCs has been demonstrated in animal models of sickle cell anemia and Parkinson’s disease (Hanna et al., 2007; Wernig et al., 2008), these cells contain multiple viral vector integrations that make them unsuitable for human clinical trials.”
BackgroundInduced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Metadata
- Authors
- Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-04-15
- Volume
- 105
- Issue
- 15
- Pages
- 5856-5861
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2103612759
- Cited by
- 1,216
- References
- 42
- FWCI
- 56.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.